Research Paper Volume 16, Issue 5 pp 4518—4540
Tumor-infiltrating macrophage associated lncRNA signature in cutaneous melanoma: implications for diagnosis, prognosis, and immunotherapy
Figure 8. Comparations between risk score and previously established prognostic markers in TCGA-SKCM. (A) Kaplan–Meier survival curve of transcriptomic subtypes. (B) The risk score distribution of transcriptomic subtypes (named “immune”, “keratin” and “MITF-low). (C) Kaplan–Meier survival curve of mutation subtypes (named BRAF subtype, RAS subtype, NF1 subtype and Triple Wild-Type subtype). (D) The risk score distribution of mutation subtypes. (E) Kaplan–Meier curve of BRAF mutant. (F) The risk score distribution of BRAF mutant and wildtype. (G) The 5 years area under the curve (AUC) of risk score and prognostic markers associated with overall survival. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001.